Baidu
map

FEBS Lett:TOP2B变异能够引起常染色体显性遗传听力损失

2019-07-03 AlexYang MedSci原创

遗传性听力损失是一种临床和遗传异质性疾病。在一个大的具有常染色体显性非综合症听力损失的中国家庭中,研究人员对7名受影响和6名不受影响的家族成员中进行了全外显子组测序。研究人员发现,编码人类拓扑异构酶IIβ TOP2B(c.G4837C:p.D1613H)的基因在该血统中与听力损失共分离,并且还在66名散发性听力损失患者中,发现了TOP2B的另外2个变异。Top2b敲除能够导致斑马鱼内耳明显的缺陷并

遗传性听力损失是一种临床和遗传异质性疾病。在一个大的具有常染色体显性非综合症听力损失的中国家庭中,研究人员对7名受影响和6名不受影响的家族成员中进行了全外显子组测序。

研究人员发现,编码人类拓扑异构酶IIβ TOP2B(c.G4837C:p.D1613H)的基因在该血统中与听力损失共分离,并且还在66名散发性听力损失患者中,发现了TOP2B的另外2个变异。Top2b敲除能够导致斑马鱼内耳明显的缺陷并引起akt下调,从而导致PI3K-Akt信号的去激活。结果是,通过对PI3K-Akt途径的抑制,支持细胞和听毛细胞的数目减少。 因此,研究人员假设TOP2B的变异能够引起常染色体显性非综合征听力损失,机理是通过对PI3K-Akt途径进行抑制来产生的。

最后,研究人员公布了他们的全外显子组测序数据在NCBI上的登录号,分别为SRR9050868, SRR9050867、SRR90508676、SRR90508675、SRR90508674、SRR90508673、SRR90508672、SRR90508671、SRR90508679、SRR90508670、SRR9050859、SRR9050858和SRR9050857。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1942993, encodeId=8c23194299309, content=<a href='/topic/show?id=080e48605e7' target=_blank style='color:#2F92EE;'>#常染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48605, encryptionId=080e48605e7, topicName=常染色体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Wed Jan 22 00:14:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748462, encodeId=a9761e484624f, content=<a href='/topic/show?id=06234861051' target=_blank style='color:#2F92EE;'>#常染色体显性遗传#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48610, encryptionId=06234861051, topicName=常染色体显性遗传)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce36134953, createdName=839640790, createdTime=Tue Jan 14 23:14:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306393, encodeId=33311306393cd, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331717, encodeId=ff851331e179d, content=<a href='/topic/show?id=d85a6181e4d' target=_blank style='color:#2F92EE;'>#染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61817, encryptionId=d85a6181e4d, topicName=染色体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342583, encodeId=8af0134258373, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1942993, encodeId=8c23194299309, content=<a href='/topic/show?id=080e48605e7' target=_blank style='color:#2F92EE;'>#常染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48605, encryptionId=080e48605e7, topicName=常染色体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Wed Jan 22 00:14:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748462, encodeId=a9761e484624f, content=<a href='/topic/show?id=06234861051' target=_blank style='color:#2F92EE;'>#常染色体显性遗传#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48610, encryptionId=06234861051, topicName=常染色体显性遗传)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce36134953, createdName=839640790, createdTime=Tue Jan 14 23:14:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306393, encodeId=33311306393cd, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331717, encodeId=ff851331e179d, content=<a href='/topic/show?id=d85a6181e4d' target=_blank style='color:#2F92EE;'>#染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61817, encryptionId=d85a6181e4d, topicName=染色体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342583, encodeId=8af0134258373, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1942993, encodeId=8c23194299309, content=<a href='/topic/show?id=080e48605e7' target=_blank style='color:#2F92EE;'>#常染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48605, encryptionId=080e48605e7, topicName=常染色体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Wed Jan 22 00:14:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748462, encodeId=a9761e484624f, content=<a href='/topic/show?id=06234861051' target=_blank style='color:#2F92EE;'>#常染色体显性遗传#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48610, encryptionId=06234861051, topicName=常染色体显性遗传)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce36134953, createdName=839640790, createdTime=Tue Jan 14 23:14:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306393, encodeId=33311306393cd, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331717, encodeId=ff851331e179d, content=<a href='/topic/show?id=d85a6181e4d' target=_blank style='color:#2F92EE;'>#染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61817, encryptionId=d85a6181e4d, topicName=染色体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342583, encodeId=8af0134258373, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=)]
    2019-07-05 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=1942993, encodeId=8c23194299309, content=<a href='/topic/show?id=080e48605e7' target=_blank style='color:#2F92EE;'>#常染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48605, encryptionId=080e48605e7, topicName=常染色体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Wed Jan 22 00:14:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748462, encodeId=a9761e484624f, content=<a href='/topic/show?id=06234861051' target=_blank style='color:#2F92EE;'>#常染色体显性遗传#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48610, encryptionId=06234861051, topicName=常染色体显性遗传)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce36134953, createdName=839640790, createdTime=Tue Jan 14 23:14:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306393, encodeId=33311306393cd, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331717, encodeId=ff851331e179d, content=<a href='/topic/show?id=d85a6181e4d' target=_blank style='color:#2F92EE;'>#染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61817, encryptionId=d85a6181e4d, topicName=染色体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342583, encodeId=8af0134258373, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1942993, encodeId=8c23194299309, content=<a href='/topic/show?id=080e48605e7' target=_blank style='color:#2F92EE;'>#常染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48605, encryptionId=080e48605e7, topicName=常染色体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Wed Jan 22 00:14:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748462, encodeId=a9761e484624f, content=<a href='/topic/show?id=06234861051' target=_blank style='color:#2F92EE;'>#常染色体显性遗传#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48610, encryptionId=06234861051, topicName=常染色体显性遗传)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce36134953, createdName=839640790, createdTime=Tue Jan 14 23:14:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306393, encodeId=33311306393cd, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1331717, encodeId=ff851331e179d, content=<a href='/topic/show?id=d85a6181e4d' target=_blank style='color:#2F92EE;'>#染色体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61817, encryptionId=d85a6181e4d, topicName=染色体)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342583, encodeId=8af0134258373, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jul 05 04:14:00 CST 2019, time=2019-07-05, status=1, ipAttribution=)]

相关资讯

盘点:听力损失治疗进展

【1】J Aging Health:老年人听力损失和助听器使用相关的特性和健康结果分析 https://www.ncbi.nlm.nih.gov/pubmed/31092107最近,有研究人员招募了老年人来探索与听力损失(HL)和助听器使用相关的生理和社会心理情况和其他健康结果。研究人员利用调查数据将20244名参与者分成了5个组:非HL组、无助听器轻度HL组、助听器轻度HL组、无助听器重度H

Eur Arch Otorhinolaryngol:听力损失儿童成长分析

最近,有研究人员根据诊断的年龄、扩音和训练情况,调查了儿童早期听力损失对他们的成长的影响。研究包括了169名患有双边感觉神经性耳聋的儿童,他们的实际平局年龄为26.4个月。所有的儿童均为单边耳蜗移植使用者且没有额外的损伤或者疾病。研究发现,169名儿童中的105名(62.1%)通过DDST-II进行了鉴定,并且没有发现异常,48名(28.4%)为疑似,16名(9.5%)发现为异常。那些在出生后6个

Am J Audiol:听力损失自我管理和助听器益处和满意度关系研究

听力损失的自我管理涉及到了人们使用的控制听力损失对日常生活影响的知识和技巧。最近,有研究人员调查了自我报道的听力损失自我管理和助听器益处以及满意度之间的相关性。研究包括了37名具有听力损失的成年人,他们均为双边听力助听器的使用者。研究发现,那些报道具有良好听力损失自我管理(听力损失对情绪表现和社交的影响的控制)的参与者在噪杂和混响环境中具有更少的辅助听力困难以及他们对助听器的影响具有更好的满意度。

Int J Audiol:住院患者的突发神经性耳聋患病率增加分析

最近,有研究人员进行了为期14年的研究来调查突发神经性耳聋流行病学发病率情况。研究是一个回顾性代表性研究。住院患者的SSNHL诊断数据时间范围为2000年到2013年,数据来源于中国台湾健康研究数据库。研究发现,总共有31258名患者包括在研究中。平均的年龄为50.30±16.70岁。男性(53.5%)诊断为SSNHL的比例要比女性(46.5%)诊断为SSNHL的概率更高。其中,出现SSNHL的患

Int J Audiol:听力损失患者生活质量研究

最近,有研究人员调查了听力损失(HL)和使用助听器(HAs)成年人的普通生活质量之间的关系。研究参与的患者完成了欧洲癌症研究和治疗组织(EORTC)生活质量调查问卷部分和自我评估交际能力的调查问卷(助听器益处简要介绍-APHAB)。研究人员将这些响应与来源于普通人群的EORTC评分和来源于前头颈癌患者的EORTC评分进行了比较。研究包括了招募之前就使用HA的158名HL患者,且他们中的一半都在寻求

盘点:听力损失研究进展

听力损失(hearing loss)又称聋度(deafness)或听力级(hearing level)。是人耳在某一频率的听阈比正常听阈高出的分贝数。由于年龄关系产生的听力损失称为老年性耳聋;由于社会环境噪声(年龄、职业性噪声和疾病等影响除外)产生的听力损失称为社会性耳聋;职业性噪声导致的听力损失称为噪声性耳聋。梅斯医学小编整理了近期听力损失的研究进展,与大家一起分享学习!【1】Am J Au

Baidu
map
Baidu
map
Baidu
map